MCPI Financials 07/16/2014 18:29:49 Med-Cannabis
Post# of 9
Med-Cannabis Pharma Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 8 - -
Cost of Revenue - - -
Gross Profit 8 - -
Operating Expenses
Research and Development - - -
Sales, General and Admin. 35 58,875 54
Non-Recurring Items 30 27 83
Other - - -
Operating Income (57) (58,902) (137)
Income From Continuing Operations
Add'l Income/Expense Items - - -
Earnings Before Interest and Tax (57) (58,902) (137)
Interest Expense 4 4 2
Earnings Before Tax (62) (58,906) (138)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (62) (58,906) (138)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (62) (58,906) (138)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (62) (58,906) (138)